our ceo appears to be slow to keep their
salary steady.
Mouse model success lacks momentum to be fast and furious for human trial. Our ceo Communicating with clinical research organisation sounds positive, but lacks aggressive attitude for commercialisation.
we heard holy grail …., but no commercial deals suggest nothing done yet to be commercial in the sight of BPs. Let them cut their salary 50% until commercial deal. Let us ignore the doctored copy-paste announcement until something material and commercial. Let them just focus on Four HIV trials and stop causing confusion re recruitment …
Enjoy your time. Our ceo is enjoying time buying time …
our ceo appears to be slow to keep their salary steady.Mouse...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.62M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $20.29K | 370.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17000 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 50922 | 1 |
View Market Depth
| Last trade - 15.45pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.5¢ |
Change
0.000 ( 1.79 %) |
||||
| Open | High | Low | Volume | ||
| 5.5¢ | 5.5¢ | 5.4¢ | 89292 | ||
| Last updated 15.45pm 06/06/2024 ? | |||||
| BIT (ASX) Chart |